Corrigendum to "Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting I κ B α /NF κ B and Enhancing Nrf2/HO-1".

Authors :: Liao HH
Zhu JX
Feng H
Ni J
Zhang N
Chen S
Liu HJ
Yang Z
Deng W
Tang QZ
Source :: Oxidative medicine and cellular longevity [Oxid Med Cell Longev] 2021 May 04; Vol. 2021, pp. 9812928. Date of Electronic Publication: 2021 May 04 (Print Publication: 2021).
Publication Year :: 2021
Abstract: [This corrects the article DOI: 10.1155/2017/8370593.].<br /> (Copyright © 2021 Hai-han Liao et al.)

Full Text Access

Tools